Autonomic dysfunction in parkinsonian disorders: Assessment and pathophysiology

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 6, 2013, Pages 674-680

  Asahina, Masato ^a   Vichayanrat, Ekawat ^b,c   Low, David A ^b,c   Iodice, Valeria ^b,c   Mathias, C J ^b,c  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Faculty of Medicine   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIPARKINSON AGENT; LEVODOPA; NORADRENALIN; SELEGILINE;

ANORECTAL PRESSURE; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE MONITORING; BRAIN ATROPHY; BRAIN DEPTH STIMULATION; CEREBRAL PALSY; CLINICAL EXAMINATION; CONSTIPATION; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; DYSAUTONOMIA; DYSPHAGIA; ELECTROGASTROGRAPHY; ELECTROMYOGRAPHY; ESOPHAGUS MOTILITY; EXERCISE TEST; FUNCTION TEST; GASTROINTESTINAL SYMPTOM; HEAD UP TILTING; HEART RATE VARIABILITY; HEAT INTOLERANCE; HUMAN; HYPERTENSION; HYPOTENSION; INTESTINE TRANSIT TIME; MEAL CHALLENGE TEST; MICTURITION DISORDER; MYOCARDIAL PERFUSION IMAGING; NEUROLOGIC EXAMINATION; NORADRENALIN BLOOD LEVEL; ORTHOSTATIC HYPOTENSION; PARKINSONISM; PATHOPHYSIOLOGY; POSTPRANDIAL HYPOTENSION; PRESSOR STIMULI TEST; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PSYCHOPATHY; PUPIL DISEASE; QUANTITATIVE SUDOMOTOR AXON REFLEX TEST; REVIEW; SEXUAL DYSFUNCTION; SHY DRAGER SYNDROME; SKIN BIOPSY; SKIN VASOMOTOR REFLEX; STOMACH EMPTYING; SUPINE HYPERTENSION; SWEAT GLAND DISEASE; SYMPATHETIC REFLEX; SYMPTOM; THERMOREGULATORY SWEATING TEST; UPPER GASTROINTESTINAL TRACT; URINARY TRACT DISEASE; URODYNAMICS; VALSALVA MANEUVER; VASOMOTOR REFLEX;

EID: 84877625990     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-303135     Document Type: Review

References (88)

1. Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001;57:456-62. (Pubitemid 32757593)
2. Hawkes CH, Del Tredici K, Braak H. A timeline for Parkinson's disease. Parkinsonism Relat Disord 2010;16:79-84.
3. Lahrmann H, Cortelli P, Hilz M, et al. EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol 2006;13:930-6. (Pubitemid 44284897)
4. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci 2011;161:46-8.
5. Verbaan D, Marinus J, Visser M, et al. Patient-reported autonomic symptoms in Parkinson disease. Neurology 2007;69:333-41. (Pubitemid 47205659)
6. Martinez-Martin P, Schapira AH, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007;22:1623-9.
7. Goldstein DS, Pechnik S, Holmes C, et al. Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension 2003;42: 136-42. (Pubitemid 36944586)
8. Vagaonescu TD, Saadia D, Tuhrim S, et al. Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet 2000;355:725-6. (Pubitemid 30107634)
9. Garland EM, Gamboa A, Okamoto L, et al. Renal impairment of pure autonomic failure. Hypertension 2009;54:1057-61.
10. Shannon JR, Jordan J, Diedrich A, et al. Sympathetically mediated hypertension in autonomic failure. Circulation 2000;101:2710-15. (Pubitemid 30390574)
11. Jansen RW, Lipsitz LA. Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med 1995;122:286-95.
12. Thomaides T, Bleasdale-Barr K, Chaudhuri KR, et al. Cardiovascular and hormonal responses to liquid food challenge in idiopathic Parkinson's disease, multiple system atrophy, and pure autonomic failure. Neurology 1993;43:900-4. (Pubitemid 23150559)
13. Micieli G, Martignoni E, Cavallini A, et al. Postprandial and orthostatic hypotension in Parkinson's disease. Neurology 1987;37:386-93. (Pubitemid 17031732)
14. Smith GD, Mathias CJ. Postural hypotension enhanced by exercise in patients with chronic autonomic failure. QJM 1995;88:251-6.
15. Bagheri H, Damase-Michel C, Lapeyre-Mestre M, et al. A study of salivary secretion in Parkinson's disease. Clin Neuropharmacol 1999;22:213-15. (Pubitemid 30004137)
16. Sakakibara R, Uchiyama T, Yamanishi T, et al. Genitourinary dysfunction in Parkinson's disease. Mov Disord 2010;25:2-12.
17. Sakakibara R, Shinotoh H, Uchiyama T, et al. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton Neurosci 2001;92:76-85. (Pubitemid 32757250)
18. Gao X, Chen H, Schwarzschild MA, et al. Erectile function and risk of Parkinson's disease. Am J Epidemiol 2007;166:1446-50. (Pubitemid 350209051)
19. Swinn L, Schrag A, Viswanathan R, et al. Sweating dysfunction in Parkinson's disease. Mov Disord 2003;18:1459-63. (Pubitemid 38035368)
20. Mizuno Y, Takubo H, Mizuta E, et al. Malignant syndrome in Parkinson's disease: concept and review of the literature. Parkinsonism Relat Disord 2003;9(Suppl 1): S3-9. (Pubitemid 36539387)
21. Micieli G, Tassorelli C, Martignoni E, et al. Disordered pupil reactivity in Parkinson's disease. Clin Auton Res 1991;1:55-8.
22. Velseboer DC, de Haan RJ, Wieling W, et al. Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 2011;17:724-9.
23. Goldstein DS. Cardiovascular autonomic dysfunction. Totowa, NJ: Humana Press, 2005.
24. Puisieux F, Bulckaen H, Fauchais AL, et al. Ambulatory blood pressure monitoring and postprandial hypotension in elderly persons with falls or syncopes. J Gerontol A Biol Sci Med Sci 2000;55:M535-40. (Pubitemid 32010280)
25. Plaschke M, Trenkwalder P, Dahlheim H, et al. Twenty-four-hour blood pressure profile and blood pressure responses to head-up tilt tests in Parkinson's disease and multiple system atrophy. J Hypertens 1998;16:1433-41. (Pubitemid 28470490)
26. DiFrancisco-Donoghue J, Elokda A, Lamberg EM, et al. Norepinephrine and cardiovascular responses to maximal exercise in Parkinson's disease on and off medication. Mov Disord 2009;24:1773-8.
27. Polinsky RJ. Neuropharmacological investigation of autonomic failure. In: Mathias CJ, Bannister R, eds. Autonomic failure a textbook of clinical disorders of the autonomic nervous system, 4th edn. Oxford: Oxford University Press, 2002:232-44.
28. Goldstein DS, Holmes C, Sharabi Y, et al. Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension. Neurology 2003;60:1327-32. (Pubitemid 36460990)
29. Maetzler W, Liepelt I, Berg D. Progression of Parkinson's disease in the clinical phase: potential markers. Lancet Neurol 2009;8:1158-71.
30. Oka H, Mochio S, Onouchi K, et al. Cardiovascular dysautonomia in de novo Parkinson's disease. J Neurol Sci 2006;241:59-65. (Pubitemid 43112517)
31. Akaogi Y, Asahina M, Yamanaka Y, et al. Sudomotor, skin vasomotor, and cardiovascular reflexes in 3 clinical forms of Lewy body disease. Neurology 2009;73:59-65.
32. Asahina M, Sakakibara R, Liu Z, et al. The raphe magnus/pallidus regulates sweat secretion and skin vasodilation of the cat forepaw pad: a preliminary electrical stimulation study. Neurosci Lett 2007;415:283-7. (Pubitemid 46400269)
33. Goldstein DS, Holmes C, Cannon RO 3rd, et al. Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 1997;336:696-702. (Pubitemid 27102684)
34. Treglia G, Cason E, Stefanelli A, et al. MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis. Clin Auton Res 2012;22:43-55.
35. Sawada H, Oeda T, Yamamoto K, et al. Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease. Eur J Neurol 2009;16:174-82.
36. Tipre DN, Goldstein DS. Cardiac and extracardiac sympathetic denervation in Parkinson's disease with orthostatic hypotension and in pure autonomic failure. J Nucl Med 2005;46:1775-81. (Pubitemid 46196637)
37. Matsui H, Udaka F, Oda M, et al. Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid. Ann Nucl Med 2005;19:225-9. (Pubitemid 40874515)
38. Fuh JL, Lee RC, Wang SJ, et al. Swallowing difficulty in Parkinson's disease. Clin Neurol Neurosurg 1997;99:106-12.
39. Bushmann M, Dobmeyer SM, Leeker L, et al. Swallowing abnormalities and their response to treatment in Parkinson's disease. Neurology 1989;39:1309-14. (Pubitemid 19246802)
40. Eadie MJ, Tyrer JH. Radiological abnormalities of the upper part of the alimentary tract in parkinsonism. Australas Ann Med 1965;14:23-7.
41. Bassotti G, Germani U, Pagliaricci S, et al. Esophageal manometric abnormalities in Parkinson's disease. Dysphagia 1998;13:28-31. (Pubitemid 28029971)
42. Arai E, Arai M, Uchiyama T, et al. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease. Brain 2012;135:1478-85.
43. Chen JZ, MaCallum RW. Electrogastrographic parameters and their clinical significance. In: Chen JD, McCallum RW, eds. Electrogastrography: principles and applications. New York: Raven Press, 1994:45-73.
44. Sakakibara Y, Asahina M, Suzuki A, et al. Gastric myoelectrical differences between Parkinson's disease and multiple system atrophy. Mov Disord 2009;24:1579-86.
45. Sakakibara R, Uchiyama T, Yamanishi T, et al. Bladder and bowel dysfunction in Parkinson's disease. J Neural Transm 2008;115:443-60.
46. Braak H, de Vos RA, Bohl J, et al. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 2006;396:67-72. (Pubitemid 43233790)
47. Stocchi F, Badiali D, Vacca L, et al. Anorectal function in multiple system atrophy and Parkinson's disease. Mov Disord 2000;15:71-6. (Pubitemid 30037990)
48. Mathers SE, Kempster PA, Swash M, et al. Constipation and paradoxical puborectalis contraction in anismus and Parkinson's disease: a dystonic phenomenon? J Neurol Neurosurg Psychiatry 1988;51:1503-7. (Pubitemid 19026520)
49. Sakakibara R, Hattori T, Uchiyama T, et al. Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 2001;71:600-6. (Pubitemid 33010573)
50. Yamamoto T, Sakakibara R, Uchiyama T, et al. Neurological diseases that cause detrusor hyperactivity with impaired contractile function. Neurourol Urodyn 2006;25:356-60. (Pubitemid 44162821)
51. Pavlakis AJ, Siroky MB, Goldstein I, et al. Neurourologic findings in Parkinson's disease. J Urol 1983;129:80-3. (Pubitemid 13148057)
52. Riley DE, Chelimsky TC. Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease. J Neurol Neurosurg Psychiatry 2003;74:56-60.
53. Kawada M, Tamada Y, Simizu H, et al. Reduction in QSART and vasoactive intestinal polypeptide expression in the skin of Parkinson's disease patients and its relation to dyshidrosis. J Cutan Pathol 2009;36:517-21.
54. Sharabi Y, Li ST, Dendi R, et al. Neurotransmitter specificity of sympathetic denervation in Parkinson's disease. Neurology 2003;60:1036-9. (Pubitemid 36348945)
55. Dabby R, Djaldetti R, Shahmurov M, et al. Skin biopsy for assessment of autonomic denervation in Parkinson's disease. J Neural Transm 2006;113:1169-76. (Pubitemid 44291012)
56. Ikemura M, Saito Y, Sengoku R, et al. Lewy body pathology involves cutaneous nerves. J Neuropathol Exp Neurol 2008;67:945-53.
57. Miki Y, Tomiyama M, Ueno T, et al. Clinical availability of skin biopsy in the diagnosis of Parkinson's disease. Neurosci Lett 2010;469:357-9.
58. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-52.
59. Wakabayashi K, Takahashi H. The intermediolateral nucleus and Clarke's column in Parkinson's disease. Acta Neuropathol 1997;94:287-9. (Pubitemid 27395331)
60. Orimo S, Takahashi A, Uchihara T, et al. Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol 2007;17:24-30.
61. Benarroch EE, Schmeichel AM, Low PA, et al. Involvement of medullary regions controlling sympathetic output in Lewy body disease. Brain 2005;128:338-44. (Pubitemid 40222602)
62. Araki I, Kitahara M, Oida T, et al. Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms. J Urol 2000;164:1640-3.
63. Kujawa K, Leurgans S, Raman R, et al. Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease. Arch Neurol 2000;57:1461-3.
64. Chase TN, Watanabe AM. Methyldopahydrazine as an adjunct to L-dopa therapy in parkinsonism. Neurology 1972;22:384-92.
65. Worth D, Harvey J, Brown J, et al. The effects of intravenous L-dopa on plasma renin activity, renal function, and blood pressure in man. Eur J Clin Pharmacol 1988;35:137-41.
66. Iwasaki S, Hamaguchi K, Iwasaki A, et al. Hypotensive effect of long-term levodopa in patients with Parkinson's disease. Eur Neurol 1990;30:194-9. (Pubitemid 20229749)
67. Senard JM, Verwaerde P, Rascol O, et al. Effects of acute levodopa administration on blood pressure and heart variability in never treated parkinsonians. Hypertens Res 1995;18(Suppl 1):S175-7.
68. Sachs C, Berglund B, Kaijser L. Autonomic cardiovascular responses in parkinsonism: effect of levodopa with dopa-decarboxylase inhibition. Acta Neurol Scand 1985;71:37-42. (Pubitemid 15156249)
69. Calne DB, Brennan J, Spiers AS, et al. Hypotension caused by L-dopa. BMJ 1970;1:474-5.
70. Haapaniemi TH, Kallio MA, Korpelainen JT, et al. Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease. J Neurol 2000;247:868-74.
71. Lyytinen J, Sovijarvi A, Kaakkola S, et al. The effect of catechol-O-methyltransferase inhibition with entacapone on cardiovascular autonomic responses in L-Dopa-treated patients with Parkinson's disease. Clin Neuropharmacol 2001;24:50-7. (Pubitemid 32176481)
72. Dive A, Foret F, Jamart J, et al. Effect of dopamine on gastrointestinal motility during critical illness. Intensive Care Med 2000;26:901-7. (Pubitemid 30616043)
73. Lanfranchi GA, Bazzocchi G, Fois F, et al. Effect of domperidone and dopamine on colonic motor activity in patients with the irritable bowel syndrome. Eur J Clin Pharmacol 1985;29:307-10. (Pubitemid 16193912)
74. Wolz M, Hauschild J, Fauser M, et al. Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson's disease. Parkinsonism Relat Disord. Published Online First: 7 June 2012.
75. Priori A, Cinnante C, Genitrini S, et al. Non-motor effects of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: preliminary physiological results. Neurol Sci 2001;22:85-6. (Pubitemid 33622094)
76. Sakakibara R, Hattori T, Tojo M, et al. Micturitional disturbance in multiple system atrophy. Jpn J Psychiatry Neurol 1993;47:591-8. (Pubitemid 23351730)
77. Yamamoto T, Sakakibara R, Uchiyama T, et al. Pelvic organ dysfunction is more prevalent and severe in MSA-P compared to Parkinson's disease. Neurourol Urodyn 2011;30:102-7.
78. Kimber JR, Watson L, Mathias CJ. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine. Lancet 1997;349:1877-81. (Pubitemid 27270122)
79. Lipp A, Sandroni P, Ahlskog JE, et al. Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. Arch Neurol 2009;66:742-50.
80. Iodice V, Lipp A, Ahlskog JE, et al. Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests. J Neurol Neurosurg Psychiatry 2012;83:453-9.
81. Asahina M, Kikkawa Y, Suzuki A, et al. Cutaneous sympathetic function in patients with multiple system atrophy. Clin Auton Res 2003;13:91-5. (Pubitemid 36628405)
82. Kimber J, Mathias CJ, Lees AJ, et al. Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy. Brain 2000;123:1422-30. (Pubitemid 30420942)
83. Kikkawa Y, Asahina M, Suzuki A, et al. Cutaneous sympathetic function and cardiovascular function in patients with progressive supranuclear palsy and Parkinson's disease. Parkinsonism Relat Disord 2003;10:101-6. (Pubitemid 37476314)
84. Larner AJ, Mathias CJ, Rossor MN. Autonomic failure preceding dementia with Lewy bodies. J Neurol 2000;247:229-31. (Pubitemid 30189411)
85. Horimoto Y, Matsumoto M, Akatsu H, et al. Autonomic dysfunctions in dementia with Lewy bodies. J Neurol 2003;250:530-3. (Pubitemid 36613294)
86. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-72. (Pubitemid 43970103)
87. Oka H, Yoshioka M, Morita M, et al. Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease. Neurology 2007;69:1460-5. (Pubitemid 47511468)
88. Sakakibara R, Ito T, Uchiyama T, et al. Lower urinary tract function in dementia of Lewy body type. J Neurol Neurosurg Psychiatry 2005;76:729-32. (Pubitemid 40569688)